View clinical trials related to Aura.
Filter by:To investigate the migraine inducing effect of levcromakalim in patients with migraine with aura.
To investigate the role of KATP channels in migraine with aura patients.
A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain.
In this study the investigators will investigate the following hypothesis - that hypoxia induce migraine headache and migraine aura - the aura phase is associated with a spreading reduction in cerebral blood flow - the migraine headache is associated with dilatation of intra- and extracerebral arteries - the migraine headache is associated with changes in brain metabolism - the pre-ictal stage of a migraine attack with aura is associated with specific patterns in neural activity.
Staccato Prochlorperazine is being developed to treat patients suffering from acute migraine headaches. In October 2005, we completed a 75 patient, multi-center, double-blind placebo-controlled Phase 2A clinical trial in patients suffering from moderate to severe acute migraine headaches. This Phase 2B clinical trial of Staccato Prochlorperazine has been initiated to assess the efficacy and safety in outpatients with migraine headache with or without aura.
The objective of the study is to investigate the safety and effectiveness of PFO closure with the BioSTAR Septal Repair Implant System in a population of patients that have refractory migraine (with aura) and who have failed medications.